Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

S Gritsch, TT Batchelor, LN Gonzalez Castro - Cancer, 2022 - Wiley Online Library
The 2016 revised fourth edition of the World Health Organization (WHO) classification of
central nervous system (CNS) tumors incorporated molecular features with histologic …

Therapeutic and prognostic insights from the analysis of cancer mutational signatures

SW Brady, AM Gout, J Zhang - Trends in Genetics, 2022 - cell.com
The somatic mutations in each cancer genome are caused by multiple mutational
processes, each of which leaves a characteristic imprint (or 'signature'), potentially caused …

Glioma progression is shaped by genetic evolution and microenvironment interactions

FS Varn, KC Johnson, J Martinek, JT Huse… - Cell, 2022 - cell.com
The factors driving therapy resistance in diffuse glioma remain poorly understood. To identify
treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA …

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

N Cosgrove, D Varešlija, S Keelan, A Elangovan… - Nature …, 2022 - nature.com
The molecular events and transcriptional plasticity driving brain metastasis in clinically
relevant breast tumor subtypes has not been determined. Here we comprehensively dissect …

[HTML][HTML] Polarization of tumor-associated macrophages by TLR7/8 conjugated radiosensitive peptide hydrogel for overcoming tumor radioresistance

Y Zhang, Z Feng, J Liu, H Li, Q Su, J Zhang, P Huang… - Bioactive materials, 2022 - Elsevier
Radioresistance reduces the antitumor efficiency of radiotherapy and further restricts its
clinical application, which is mainly caused by the aggravation of immunosuppressive tumor …

Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution

K Thol, P Pawlik, N McGranahan - Genome Medicine, 2022 - Springer
Cancer development is an evolutionary process. A key selection pressure is exerted by
therapy, one of the few players in cancer evolution that can be controlled. As such, an …

Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features

L Nguyen, A Van Hoeck, E Cuppen - Nature communications, 2022 - nature.com
Cancers of unknown primary (CUP) origin account for∼ 3% of all cancer diagnoses,
whereby the tumor tissue of origin (TOO) cannot be determined. Using a uniformly …

A radiologist's guide to the 2021 WHO Central Nervous System Tumor Classification: part I—key concepts and the spectrum of diffuse gliomas

DR Johnson, C Giannini, RA Vaubel, JM Morris… - Radiology, 2022 - pubs.rsna.org
The fifth edition of the World Health Organization (WHO) classification of tumors of the
central nervous system, published in 2021, contains substantial updates in the classification …

Preoperative diagnosis and molecular characterization of gliomas with liquid biopsy and radiogenomics

C Balana, S Castañer, C Carrato, T Moran… - Frontiers in …, 2022 - frontiersin.org
Gliomas are a heterogenous group of central nervous system tumors with different outcomes
and different therapeutic needs. Glioblastoma, the most common subtype in adults, has a …

Salmonella as a Promising Curative Tool against Cancer

RP Aganja, C Sivasankar, A Senevirathne, JH Lee - Pharmaceutics, 2022 - mdpi.com
Bacteria-mediated cancer therapy has become a topic of interest under the broad umbrella
of oncotherapy. Among many bacterial species, Salmonella remains at the forefront due to …